Scotiabank raises Cemex stock price target to $10.90 on lower rates

Published 02/09/2025, 13:02
Scotiabank raises Cemex stock price target to $10.90 on lower rates

Investing.com - Scotiabank raised its price target on CEMEX (NYSE:CX) to $10.90 from $8.10 on Tuesday, representing a 35% increase, while maintaining a Sector Outperform rating on the cement maker’s stock. The new target comes as CEMEX trades near its 52-week high of $9.19, having delivered impressive returns of over 62% year-to-date.

The price target adjustment reflects Scotiabank’s revised assumptions for the U.S. 10-Year Treasury yield, which the bank’s economists now expect to reach 4.25% rather than the previously forecasted 4.75%. According to InvestingPro data, CEMEX maintains a healthy financial profile with a "GOOD" overall score, suggesting resilience to interest rate fluctuations.

This interest rate outlook change led Scotiabank to reduce its cost of equity calculation for CEMEX from 15.0% to 12.88%, while the weighted average cost of capital (WACC) decreased from 10.7% to 9.31%.

Scotiabank also made minor adjustments to its EBITDA forecasts for the company, incorporating more conservative volume projections for Mexico due to intense summer rainfall in the region.

The bank noted that a stronger Mexican peso compared to its April 2025 forecast was another factor in its updated financial model for the cement and building materials company.

In other recent news, Cemex has announced several significant developments that may interest investors. The company has successfully closed a $1 billion subordinated notes offering, which was sold to qualified institutional buyers and non-U.S. persons. Additionally, Cemex will distribute a cash dividend totaling $130 million, with the first installment scheduled for June 18, 2025. This dividend will be paid in four equal installments, benefiting holders of Cemex Ordinary Participation Certificates and American Depositary Shares.

In terms of stock evaluations, JPMorgan has upgraded Cemex’s stock rating from Neutral to Overweight, citing a cost-saving program and raising the price target to $10.50. Meanwhile, BofA Securities has increased its price target for Cemex to $8.00, maintaining a Neutral rating, due to a lower cost of capital in its valuation model. These analyst actions reflect differing perspectives on Cemex’s financial strategies and market positioning.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.